240 related articles for article (PubMed ID: 17938571)
21. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection.
Cheong JY; Cho SW; Chung SG; Lee JA; Yeo M; Wang HJ; Lee JE; Hahm KB; Kim JH
Biochem Genet; 2006 Jun; 44(5-6):246-55. PubMed ID: 16944293
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
[TBL] [Abstract][Full Text] [Related]
23. Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.
Gormus U; Ergen A; Yilmaz H; Dalan B; Berkman S; Isbir T
Anticancer Res; 2007; 27(2):991-4. PubMed ID: 17465232
[TBL] [Abstract][Full Text] [Related]
24. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
Zhang W; Li C; Wang J; He C
Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365
[TBL] [Abstract][Full Text] [Related]
25. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
26. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis.
Zhang H; Sun XF; Synnerstad I; Rosdahl I
Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757
[TBL] [Abstract][Full Text] [Related]
27. Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules.
Arasteh JM; Sarvestani EK; Aflaki E; Amirghofran Z
Immunol Invest; 2010; 39(1):27-38. PubMed ID: 20064083
[TBL] [Abstract][Full Text] [Related]
28. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
[TBL] [Abstract][Full Text] [Related]
30. Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
Kobak Ş; Berdeli A
Reumatismo; 2012 Dec; 64(6):374-9. PubMed ID: 23285481
[TBL] [Abstract][Full Text] [Related]
31. Functional variants in cell death pathway genes and risk of pancreatic cancer.
Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
[TBL] [Abstract][Full Text] [Related]
32. [Association of TNFA polymorphisms with the outcomes of HBV infection].
Liu Y; Guo XH; Du T; Li JH; Zhu XL; Gao JR; Lu LP; Gou CY; Li Z; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):406-10. PubMed ID: 16086278
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
34. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
35. Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.
Geleijns K; Laman JD; van Rijs W; Tio-Gillen AP; Hintzen RQ; van Doorn PA; Jacobs BC
J Neuroimmunol; 2005 Apr; 161(1-2):183-9. PubMed ID: 15748958
[TBL] [Abstract][Full Text] [Related]
36. Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma.
Lee SK; Kim MH; Cheong JY; Cho SW; Yang SJ; Kwack K
Liver Int; 2009 Feb; 29(2):187-95. PubMed ID: 18694400
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
Obika M; Shinji T; Fujioka S; Terada R; Ryuko H; Lwin AA; Shiraha H; Koide N
Intervirology; 2008; 51(1):59-68. PubMed ID: 18349544
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
39. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
[TBL] [Abstract][Full Text] [Related]
40. Association of functional polymorphism of ApoB promoter with hepatitis C virus infection.
Zhu C; Zhang R; Liu D; Mukhtar MM; Liu W; Peng G; Wang K; Hao Q; Xu Y; Liu F; Zhu Y; Wu J
Clin Chim Acta; 2009 Mar; 401(1-2):124-7. PubMed ID: 19083997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
